NTRK2 and Huntington disease: Although there was no significant difference between iPS-NSCs treated HD mice and HD vehicle controls in levels of BDNF (p = 0.24), and TrkB (p = 0.31), levels were also not significantly different in iPS-NSCs-treated HD mice when compared to WT mice, suggesting an intermediate treatment effect.